2010 CCS Antiplatelet Guidelines: The Use of Antiplatelet Therapy in the Outpatient Setting Disclosures of Conflict of Interests Member Has an affiliation - Pharmaceutical industry in the United Kingdom - Document - PDFSEARCH.IO

First Page	Meta Content
	2010 CCS Antiplatelet Guidelines: The Use of Antiplatelet Therapy in the Outpatient Setting Disclosures of Conflict of Interests Member Has an affiliation Add to Reading List Document Date: 2014-03-09 19:12:30 Open Document File Size: 84,96 KB Share Result on Facebook Company Eli Lilly / Pfizer / Schering / GlaxoSmithKline / Johnson & Johnson / Bayer / Novartis / Merck / AstraZeneca / Bristol-Myers Squibb / Daiichi Sankyo Inc / / Organization Cystic Fibrosis Foundation / CIHR / Quebec Diabetes Association / / Person A. Graham Turpie Robert / François Tanguay Boehringer Ingelheim / Philip Teal / Michael P. Love Yes Neesh Pannu / Robert C. Welsh Jean / James D. Douketis Yes Anil Gupta / Alan D. Bell / Leo Pharma / André Roussin / Thomas F. Lindsay / Maria E. Kraw / F. Lindsay Yes / Raymond Cartier Wee Shian Chan / / Position Investigator / Officer / director / guideline Consulting fees/ Honoraria Officer / director / / SocialTag Pharmaceutical sciences Pharmaceutical industry in the United Kingdom Sanofi Pharmaceutical industry Pharmaceutical Research and Manufacturers of America

2010 CCS Antiplatelet Guidelines: The Use of Antiplatelet Therapy in the Outpatient Setting Disclosures of Conflict of Interests Member Has an affiliationAdd to Reading List